Shanghai Pharmaceutical Co., Ltd. Subsidiary Accused Of Bribery

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

December 17, 2013 -- A Shanghai Pharmaceuticals subsidiary has been accused of bribing hospital staff to prescribe its drugs. According to a whistleblower, Qingdao Growful Pharma paid 766,500 RMB ($126,300) in bribes to boost sales of an iron supplement, Hong Yuan Da. The report alleges the bribes went to staff members of 31 hospitals in Qingdao during the first six months of 2013. More details.....

Stock Symbol: (SHA: 601607; HK: 2607)

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC